Research
Education
Healthcare
Community
About
Jul 01, 2026 | ProBio Inc.
ProBio's AAV Manufacturing Excellence Powers UC Irvine and GlyTR Therapeutics First‑in‑Class Pan-Cancer CAR‑T Program
UC Irvine researchers and GlyTR Therapeutics have advanced a groundbreaking, first-in-class pan-cancer CAR-T platform with the potential to expand the reach of cell therapy into solid tumors.
Jun 23, 2026 | UC Irvine School of Medicine
Researchers Develop a Potential Blood Test for Diagnosing ALS
UC Irvine researchers are part of an international team developing a new blood test to diagnose ALS and track its progression.
Jun 18, 2026 | UC Irvine School of Medicine
CBD to Alleviate ‘Chemo Brain’ in Cancer Survivors
A new study by UC Irvine researchers suggests that CBD can help treat “brain fog” for people with cancer-therapy-related cognitive impairments (CRCI), addressing an unmet medical need.
Matt Miller Director mrmille2@uci.edu
Michelle Heath Manager mstrombe@hs.uci.edu
Shani Murray Senior Science Writer shanim@hs.uci.edu
Communications & PR Office
Stay Connected
In this episode of the Translational Addiction Podcast, the hosts interview alumni Ron Broide, PhD, the executive director of biological research at AbbVie.
A physician-scientist and clinical trial leader, Chow will drive the next phase of strategic growth by expanding innovative clinical care, translational research, precision medicine and multidisciplinary partnerships.
A new study led by researchers at UC Irvine and Mass General Brigham-affiliated McLean Hospital points to biomarker-guided care to improve antidepressant response rates and reduce trial-and-error prescribing.
Jul 06, 2026 | Orange County Business Journal
UCI Names Stamos Interim Health Affairs VC
A leadership change is underway at UCI’s academic health enterprise. Dr. Steve Goldstein, vice chancellor of health affairs, is departing …. Stepping into the role on an interim basis is Dr. Michael Stamos, dean of the UC Irvine School of Medicine. He will continue to serve as dean while the university conducts a national search.
Jul 03, 2026 | The Washington Post
I Said Yes to an Alzheimer's Blood Test. Then I Panicked.
Unlike a blood draw, a result can have a blast radius that reaches far beyond the exam room — into your family, your finances, your future. Once this information is out, cautioned Joshua Grill, a professor at the University of California, Irvine and director of UCI MIND who has received research funding from makers of Alzheimer’s drugs and diagnostic tests, “you cannot put the toothpaste back in the tube.”